Literature DB >> 29323061

Accuracy of vascular invasion reporting in hepatocellular carcinoma before and after implementation of subspecialty surgical pathology sign-out.

Aaron R Huber1, Raul S Gonzalez1, Mark S Orloff2, Christopher T Barry3, Christa L Whitney-Miller1.   

Abstract

CONTEXT: Liver cancers (including hepatocellular carcinoma [HCC] and cholangiocarcinoma) are the fifth most common cause of cancer death. The most powerful independent histologic predictor of overall survival after transplantation for HCC is the presence of microscopic vascular invasion (VI). AIMS: Given that VI is known to have somewhat high interobserver variability in both HCC and other tumors, we hypothesized that pathologists with special interest and training in liver pathology would be more likely to identify and report VI in HCC than would general surgical pathologists. SETTINGS AND
DESIGN: We searched our departmental surgical pathology archives for transplant hepatectomies performed for HCC. SUBJECTS AND METHODS: We identified 143 such cases with available sign-out reports and hematoxylin and eosin-stained slides. STATISTICAL ANALYSIS USED: Kappa results (level of agreement) were calculated.
RESULTS: Before surgical pathology subspecialty sign-out (SSSO) implementation, 49 of 88 HCC cases were reported as negative for VI; on rereview, 20 of these had VI. After SSSO implementation, 39 of 55 cases were reported as negative for VI; on our review, 8 of these had VI. Kappa (agreement) between general SO and subspecialty rereview was 0.562 (95% confidence interval [CI] = 0.411-0.714) "weak agreement." Kappa (agreement) between SSSO and rereview by select liver pathologists was 0.693 (95% CI = 0.505-0.880) "moderate agreement."
CONCLUSIONS: Our study is one of only a few so far that have suggested improved accuracy of certain parameters under SSSO.

Entities:  

Mesh:

Year:  2017        PMID: 29323061     DOI: 10.4103/IJPM.IJPM_827_16

Source DB:  PubMed          Journal:  Indian J Pathol Microbiol        ISSN: 0377-4929            Impact factor:   0.740


  4 in total

Review 1.  What is the optimal surgical treatment for hepatocellular carcinoma beyond the debate between anatomical versus non-anatomical resection?

Authors:  Naoya Sato; Shigeru Marubashi
Journal:  Surg Today       Date:  2021-08-14       Impact factor: 2.549

2.  FAT10 promotes hepatocellular carcinoma (HCC) carcinogenesis by mediating P53 degradation and acts as a prognostic indicator of HCC.

Authors:  Yue Zhang; Zhifan Zuo; Bo Liu; Pinghua Yang; Jun Wu; Lei Han; Tao Han; Tingsong Chen
Journal:  J Gastrointest Oncol       Date:  2021-08

3.  Circ-SPECC1 modulates TGFβ2 and autophagy under oxidative stress by sponging miR-33a to promote hepatocellular carcinoma tumorigenesis.

Authors:  Bin Zhang; Zhiyi Liu; Kuan Cao; Wengang Shan; Jin Liu; Quan Wen; Renhao Wang
Journal:  Cancer Med       Date:  2020-07-06       Impact factor: 4.452

4.  SPAG5 promotes hepatocellular carcinoma progression by downregulating SCARA5 through modifying β-catenin degradation.

Authors:  Hongliang Liu; Junwen Hu; Ran Wei; Longfei Zhou; Hua Pan; Hongchao Zhu; Mingwen Huang; Jun Luo; Wei Xu
Journal:  J Exp Clin Cancer Res       Date:  2018-09-18
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.